氯化钡预处理对急性呼吸窘迫综合征小鼠肺的保护作用
该研究将60只8-12周龄健康C57BL/6雄性小鼠随机分为对照组、ARDS模型组和氯化钡预处理组,每组20只。氯化钡预处理组建模前连续3天经尾静脉注射氯化钡(4 mg/kg),ARDS模型经气管内注射LPS(3 mg/kg)建立。结果显示,与ARDS模型组相比,氯化钡预处理组肺湿/干重比(4.620±0.125 vs. 4.951±0.161)和肺组织伊文思蓝含量(μg/g:0.108±0.011 vs. 0.130±0.027)均显著降低(均P<0.01),肺病理评分(5.00±1.00 vs. 10.33±1.15)和支气管肺泡灌洗液TNF-α水平(ng/L:169.16±73.33 vs. 900.85±247.80)均显著下降(均P<0.01)。作者认为氯化钡对LPS攻击的ARDS小鼠模型具有保护作用。
要点
- 小鼠ARDS模型经气管内注射LPS(3 mg/kg)建立,氯化钡预处理为建模前连续3天经尾静脉注射氯化钡(4 mg/kg)。
- 氯化钡预处理组肺湿/干重比4.620±0.125,低于ARDS模型组的4.951±0.161(P<0.01)。
- 氯化钡预处理组肺组织伊文思蓝含量0.108±0.011 μg/g,低于ARDS模型组的0.130±0.027 μg/g(P<0.01)。
- 氯化钡预处理组肺病理评分5.00±1.00,低于ARDS模型组的10.33±1.15(P<0.01)。
- 氯化钡预处理组支气管肺泡灌洗液TNF-α水平169.16±73.33 ng/L,低于ARDS模型组的900.85±247.80 ng/L(P<0.01)。
适用人群与场景
- 60只8-12周龄健康C57BL/6雄性小鼠,随机分为对照组、ARDS模型组和氯化钡预处理组,每组20只。
处置流程与药物剂量
- 氯化钡预处理组于ARDS模型建立前连续3天经尾静脉注射氯化钡(4 mg/kg)。
- ARDS模型经气管内注射LPS(3 mg/kg)建立;对照组气管内给予等体积0.9%氯化钠溶液。
研究设计与关键结果
- 研究类型为小鼠实验;与对照组相比,ARDS模型组肺湿/干重比升高(4.951±0.161 vs. 3.449±0.299,P<0.01),肺组织伊文思蓝含量升高(μg/g:0.130±0.027 vs. 0.085±0.011,P<0.01),肺病理评分升高(10.33±1.15 vs. 1.67±0.58,P<0.01),支气管肺泡灌洗液TNF-α水平升高(ng/L:900.85±247.80 vs. 68.21±5.79,P<0.01),并出现肺泡壁结构破坏、肺淤血、肺泡渗出物及大量炎性细胞等典型ARDS病理改变。
- 与ARDS模型组相比,氯化钡预处理组肺湿/干重比降低(4.620±0.125 vs. 4.951±0.161,P<0.01),肺组织伊文思蓝含量降低(μg/g:0.108±0.011 vs. 0.130±0.027,P<0.01),肺病理评分降低(5.00±1.00 vs. 10.33±1.15,P<0.01),支气管肺泡灌洗液TNF-α水平降低(ng/L:169.16±73.33 vs. 900.85±247.80,P<0.01),受损肺结构显著减轻。
证据类型、等级与局限
- 证据类型:小鼠实验(动物实验)。
- 作者结论:氯化钡预处理可通过降低肺毛细血管通透性和局部炎症反应改善LPS诱导的ARDS模型小鼠肺组织病理改变;氯化钡对LPS攻击的ARDS小鼠模型具有保护作用。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文为小鼠实验,作者认为氯化钡对LPS攻击的ARDS小鼠模型具有保护作用;原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore whether barium chloride (BaCl2) preconditioning has the protective effect on lipopolysaccharide (LPS)-induced acute respiratory distress syndrome (ARDS) model in mice and the possible mechanism.
METHODS: Sixty 8-12 week old healthy C57BL/6 male mice were randomly divided into control group, ARDS model group and BaCl2 pretreatment group, with 20 mice in each group. The BaCl2 pretreatment group was continuously injected with BaCl2 (4 mg/kg through the tail vein) for 3 days before ARDS model establishment. ARDS model was established by intratracheally injecting (3 mg/kg) LPS. The control group was intratracheally given the same volume of 0.9% normal saline. On 24th hour after ARDS model establishment, some mice were sacrificed for obtaining fresh lung tissue. And the right lower lobe of the lung was separated for observing the pathological changes of lung tissue while the left lung tissue was used to measure the wet/dry weight ratio (W/D) of the lung. Some mice were sacrificed for observing pulmonary microvascular permeability at 2nd hours after injecting Evans blue (EB) through tail vein. The left mice were killed for alveolar lavage to measure the levels of tumor necrosis factor-α (TNF-α) via enzyme linked immunosorbent assay (ELISA).
RESULTS: Comparing with the control group, ARDS model group showed typical ARDS pathological changes, which included the increased W/D ratio (4.951±0.161 vs. 3.449±0.299, P < 0.01) and the content of EB in the lung tissue (μg/g: 0.130±0.027 vs. 0.085±0.011, P < 0.01), the damaged alveolar wall structure, lung congestion and exudates in the alveoli, as well as amounts of inflammatory cells. The pathological score of lung injury (10.33±1.15 vs. 1.67±0.58) and the level of TNF-α in BALF (ng/L: 900.85±247.80 vs. 68.21±5.79) were significantly increased in the ARDS model group (both P < 0.01). Comparing with the ARDS model group, the lung W/D ratio (4.620±0.125 vs. 4.951±0.161) and the EB content in the lung tissue (μg/g: 0.108±0.011 vs. 0.130±0.027) of BaCl2 pretreatment group were significantly reduced (both P < 0.01). And the damaged pulmonary structural BaCl2 pretreatment group were significantly alleviated. In addition, the pulmonary pathological score (5.00±1.00 vs. 10.33±1.15) and the level of TNF-α in BALF (ng/L: 169.16±73.33 vs. 900.85±247.80) were significantly decreased (both P < 0.01).
CONCLUSIONS: Barium chloride pretreatment can improve the lung histopathological changes of ARDS model mice induced by LPS by reducing the permeability of pulmonary capillaries and local inflammatory reaction.Barium chloride has the protective effect against LPS attack in mice model of ARDS.
参考来源
- Wang Y, Yang H, Li W, et al. [Protective effect of barium chloride pretreatment on lung in mice with acute respiratory distress syndrome]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 36916340. doi:10.3760/cma.j.cn121430-20221020-00932
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。